A drug used to help patients lose weight and manage diabetes may also help those with heart failure, an international clinical trial shows. The test of tirzepatide, brand named Zepbound, included 731 ...
Share on Pinterest Weight loss drugs could help improve health outcomes in people with heart failure. The Good Brigade/Getty Images Researchers report that the weight loss drugs semaglutide and ...
Despite an increase in prescription rates of mineralocorticoid receptor antagonists (MRAs) for patients with heart failure with reduced ejection fraction (HFrEF) in the United Kingdom from 2014 to ...
Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with obesity and heart failure with preserved pump function, new research reveals. Weight ...
SAN FRANCISCO, CA, UNITED STATES, September 24, 2025 /EINPresswire.com/ -- RhythmScience, a leader in cardiac data management solutions, today announced it has ...
How would you summarize your study for a lay audience? Heart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart failure is classified ...
Morning Overview on MSN
Doctors surprised by semaglutide’s heart-saving benefits
For years, semaglutide was framed as a powerful tool for diabetes and weight loss. Now cardiologists are confronting a more ...
New research found that the medication spironolactone, often prescribed for hypertension (high blood pressure), may reduce the risk of heart failure in people recovering from a heart attack. However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback